Dexmedetomidine has become an increasingly popular alternative to benzodiazepines and opioids as a safe agent for sedation and pain control, especially in pediatric populations. In this study, we present a case of postoperative use of dexmedetomidine in a pediatric patient, with a known history of behavioral difficulties, who underwent stereotactic lead placement for medically refractory epilepsy.
|Number of pages||4|
|Journal||Journal of Pediatric Neurology|
|State||Published - 1 Jun 2020|
- stereotactic lead placement